Inactive Instrument

News Small Pharma Inc.

Equities

DMT

CA8316641072

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

Small Pharma Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended November 30, 2023	Jan. 29	CI
Canadian Investment Regulatory Organization Trading Halt - DMT	23-10-23	AQ
Small Pharma Brief: Cybin Completed Acquisition of Small Pharma Inc. to Create International Clinical-stage Leader in Novel Psychedelic Therapeutics	23-10-23	MT
Cybin Inc. completed the acquisition of Small Pharma Inc. (TSXV : DMT).	23-10-22	CI
Small Pharma Brief: Shareholders overwhelmingly voted in favour of Cybin's acquisition	23-10-19	MT
Small Pharma Brief: Q2 FY24 Highlights Include Cash on hand as of August 31, 2023 of approximately C$7.7 million	23-10-19	MT
Small Pharma Reports Fiscal Second Quarter 2024 Highlights	23-10-19	GL
Small Pharma Reports Fiscal Second Quarter 2024 Highlights	23-10-19	AQ
Tranche Update on Small Pharma Inc.'s Equity Buyback Plan announced on August 18, 2022.	23-10-19	CI
Small Pharma Inc. Reports Earnings Results for the Second Quarter and Six Months Ended August 31, 2023	23-10-19	CI
Cybin Inc. - Small Pharma Obtains Final Order Approving Arrangement	23-10-18	AQ
Small Pharma Announces Voting Results from Annual General and Special Meeting of Shareholders	23-10-12	GL
Disposition of Common Shares of Small Pharma Inc.	23-10-02	GL
Disposition of Common Shares of Small Pharma Inc.	23-10-02	AQ
Cybin Inc. - Small Pharma Reports Positive Top-line Data from SPL026 (DMT)-SSRI Drug Interaction Study in Patients with Major Depressive Disorder	23-09-28	AQ
DMT-SSRI combination shows potential for depression	23-09-27	AQ
Small Pharma Notes Positive Top-line Data from SPL026-SSRI Drug Interaction Study in Patients with Major Depressive Disorder	23-09-26	MT
Small Pharma Brief: Reporting "Positive" Top-line Data from SPL026 (DMT)-SSRI Drug Interaction Study in Patients with Major Depressive Disorder	23-09-26	MT
Small Pharma Reports Positive Top-line Data from SPL026 (DMT)-SSRI Drug Interaction Study in Patients with Major Depressive Disorder	23-09-26	GL
Small Pharma Inc. Reports Positive Top-line Data from SPL026 (DMT-SSRI Drug Interaction Study in Patients with Major Depressive Disorder	23-09-26	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Small Pharma Inc.

Equities

DMT

CA8316641072

Summary

Filters